Collection of Biological Specimens and Associated Health Information
Launched by OVATION.IO, INC. · Apr 11, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial aims to collect blood samples from individuals who have been diagnosed with cancer. The goal is to create a large database that researchers can use to find new ways to detect and treat cancer and other diseases. By studying these blood samples, researchers hope to learn more about how genes influence health and illness, which could lead to better treatments in the future.
To participate, individuals must be at least 18 years old and currently receiving care at one of the participating clinics. They should have a confirmed diagnosis of cancer, which includes solid tumors or blood cancers. It’s important to note that people who cannot provide informed consent or those who are currently prisoners are not eligible for this study. Participants will have the opportunity to contribute to important research that could help improve cancer care for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Are patients of participating study site clinics/clinical groups
- • Are adults (aged 18 or older)
- • Have an active cancer diagnosis with confirmatory pathology results indicating solid tumor and/or hematologic malignancy
- • Participants may have other active diagnoses with confirmatory clinical results
- Exclusion Criteria:
- • Individuals who lack the capacity to provide informed consent
- • Individuals known to be prisoners at time of biological specimen collection
About Ovation.Io, Inc.
Ovation.io, Inc. is a pioneering clinical trial sponsor focused on advancing innovative therapeutic solutions through robust research and development. With a commitment to enhancing patient outcomes, the company leverages cutting-edge technology and data analytics to streamline clinical trial processes, ensuring efficiency and accuracy in study execution. Ovation.io collaborates closely with healthcare providers, regulatory bodies, and academic institutions to transform clinical insights into actionable strategies, ultimately aiming to bring novel treatments to market that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Maine, United States
Patients applied
Trial Officials
Pauline Gee, PhD
Study Director
VP, Clinical Affairs, Ovation.io
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported